| http://www.w3.org/ns/prov#value | - Additionally Big Pharma companies, such as Merck & Co. and Pfizer, have expressed a strategic interest in biosimilars, and certain companies, such as Novartis (through its generic-drug arm Sandoz), are currently positioned in the FOB market.
|
